Celldex Therapeutics
This senior Regulatory Affairs leadership role focuses on early-stage CMC regulatory strategy and provides broad regulatory science expertise across the company's portfolio. The position supports product advancement from IND through late-stage development while serving as a senior advisor on complex issues spanning Clinical, CMC, Quality, Manufacturing, and Regulatory functions. The role involves partnering with cross-functional teams to strengthen development-phase CMC strategy, GMP compliance, and inspection readiness.
Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering immunology-based therapies to treat severe inflammatory, allergic, and autoimmune diseases. Their lead program, barzolvolimab, is a humanized monoclonal antibody inhibitor of KIT designed to target mast cells as a core driver of disease. The company leverages deep expertise in antibody-based immunotherapies and proprietary technologies to discover and develop innovative treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Celldex Therapeutics.
3% above the average for this role